Simultaneous determination of losartan and active metabolite EXP3174 in rat plasma by HPLC with column switching

被引:26
|
作者
Lee, H
Shim, HO
Lee, HS
机构
[1] KOREA RES INST CHEM TECHNOL,SCREENING & TOXICOL CTR,TAEJON 305606,SOUTH KOREA
[2] WONKWANG UNIV,COLL PHARM,IKSAN 570749,SOUTH KOREA
关键词
column liquid chromatography; column-switching; losartan and EXP3174 in plasma;
D O I
10.1007/BF02271053
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new liquid chromatographic method with column-switching has been developed for the simultaneous determination of losartan and its active metabolite, EXP3174 in rat plasma. The plasma sample was injected onto a precolumn of LiChroprep RP-8 after dilution with 5% acetonitrile in 50 mM phosphoric acid. Polar plasma components were eluted using this diluent. After valve switching, the concentrated drugs were eluted in the back-flush mode and separated by an Inertsil ODS-2 column with acetonitrile-acetate buffer. The method showed excellent precision, accuracy and speed with detection limit 20 ng mL(-1). Total analysis time per sample was less than 40 min and the coefficients of variation for intra and inter-assay were 4.8%. This method has been successfully applied after oral administration of losartan to rat plasma samples.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 50 条
  • [1] EXP3174: The major active metabolite of losartan
    Tamaki, T
    Nishiyama, A
    Kimura, S
    Aki, Y
    Yoshizumi, M
    Houchi, H
    Morita, K
    Abe, Y
    CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (02): : 122 - 136
  • [2] Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC-PDA
    Wani, Taha U.
    Mir, Khalid B.
    Raina, Arun
    Dar, Alamgir A.
    Jan, Ishrat
    Khan, Nisar A.
    Wani, Taseen A.
    Sofi, Javid A.
    Hassan, G. I.
    Almoallim, Hesham S.
    Alharbi, Sulaiman Ali
    Ansari, Mohammad Javed
    Alfarraj, Saleh
    Tarique, Mohammed
    Dar, Showket A.
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (08)
  • [3] Pharmacokinetics of Losartan and its Active Metabolite EXP3174 in Healthy Iranian Subjects
    Hossein Amini
    Abolhassan Ahmadiani
    Maryam Moazenzadeh
    Clinical Drug Investigation, 2004, 24 : 619 - 623
  • [4] Pharmacokinetics of losartan and its active metabolite EXP3174 in healthy Iranian subjects
    Amini, H
    Ahmadiani, A
    Moazenzadeh, M
    CLINICAL DRUG INVESTIGATION, 2004, 24 (10) : 619 - 623
  • [5] Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats
    Zhao, Qingling
    Wei, Jinlan
    Zhang, Hongying
    XENOBIOTICA, 2019, 49 (05) : 563 - 568
  • [6] Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
    Lo, MW
    Goldberg, MR
    McCrea, JB
    Lu, H
    Furtek, CI
    Bjornsson, TD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) : 641 - 649
  • [7] Losartan and its active metabolite EXP3174: Estimation of partial clearances in in-vitro and in-vivo rat studies
    Dressler, C
    Langguth, P
    Ader, P
    Spahn-Langguth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R6 - R6
  • [8] Inhibition of proximal tubular fluid absorption by losartan and its metabolite EXP3174 in the anesthetised rat
    Smart, ML
    Hiranyachattada, S
    Harris, PJ
    JOURNAL OF HYPERTENSION, 1998, 16 : S126 - S126
  • [9] Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry
    Polinko, M
    Riffel, K
    Song, HC
    Lo, MW
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 33 (01) : 73 - 84
  • [10] Pre-treatment with Curcumin Enhances Plasma Concentrations of Losartan and Its Metabolite EXP3174 in Rats
    Liu, An-Chang
    Zhao, Li-Xia
    Xing, Jie
    Liu, Tian
    Du, Fu-Ying
    Lou, Hong-Xiang
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (02) : 145 - 150